BioSpace: As H-1B Visa Changes Keep Coming, Biopharmas Adjust Hiring Approach

As H-1B visa policies continue to evolve, biopharma companies face new challenges in attracting and retaining global talent. In an article published by BioSpace, Partner Audrea Golding discussed how the $100,000 fee has influenced hiring decisions, particularly among startups, and how the weighted selection process and proposed policy changes could further affect workforce planning.

Read more here.